Effect of Ruta graveolens Extract on the Major Virulence Factors in Methicillin Resistant Staphylococcus aureus
Shahinda Rezk,Omar Alqabbasi,Asmaa Ramadan,Mohamed Turkey
DOI: https://doi.org/10.2147/IDR.S393912
2022-12-07
Infection and Drug Resistance
Abstract:Shahinda Rezk, 1 Omar Alqabbasi, 2 Asmaa Ramadan, 3, 4 Mohamed Turkey 5 1 Microbiology Department, Medical Research Institute, Alexandria University, Alexandria, Egypt; 2 Biology Department, Faculty of Science, Benghazi University, Benghazi, Libya; 3 Microbiology and Biotechnology Department, College of Pharmacy, Arab Academy for Science, Technology and Maritime Transport, Alexandria, Egypt; 4 Pharmacy Department, Ministry of Health and Population, Alexandria, Egypt; 5 Microbiology and Immunology Department, Faculty of Pharmacy, October 6 University, Sixth of October City, Giza, 12585, Egypt Correspondence: Shahinda Rezk, Microbiology Department, Medical Research Institute, Alexandria University, 169 Horreya Road, Al Ibrahimeyah Qebli WA Al Hadrah Bahri, Bab Sharqi, Alexandria, 21561, Egypt, Tel +20 1023020030, Fax +20 34283543, Email Purpose: Rising Antibiotic Resistance has put the world in real threat. Methicillin resistant Staphylococcus aureus (MRSA), is a predominant cause of suppurative chronic skin and soft-tissue infections. Novel insights have focused the light on plant extracts. In this study, Ruta graveolens ethanolic active extract was tested for its potential anti-virulence activities in MRSA. Materials and Methods: A total of 100 MRSA strains causing skin and soft tissue infections were isolated and antibiotic susceptibility testing was done. Ability to form biofilm was tested phenotypically. Furthermore, the antimicrobial activity of Ruta graveolens was evaluated followed by detection of its Minimum inhibitory concentration (MIC). The inhibitory activity of this extract on biofilm formation was investigated. Afterwards, we investigated its effect on the transcription of biofilm-related genes and mecA gene. Results: All tested isolates were sensitive to Vancomycin and Linezolid while high resistance was noted with both Fusidic acid (83%) and Gentamicin (68%). (83%) of the isolates were biofilm producers. Ruta graveolens extract showed strong antimicrobial activity against the MRSA strains with MIC 0.78 mg/mL. At subinhibitory concentration (1/2 MIC), the extract had high biofilm inhibitory effects with mean inhibition (70%). Moreover, transcriptional analysis results showed that the mean percentages of inhibition in expression of mecA, icaA and icaD genes were 52.3%, 34.8% and 33.7%, respectively, in which all showed statistically significant difference ( p ≤ 0.05). Conclusion: The current study proposes the ability of Ruta graveolens extract to reduce the biofilm formation and antibiotic resistance of MRSA through downregulation of some biofilm forming genes and mecA gene which confers resistance to B-lactam antibiotics. This may decrease our reliance on antibiotics and improve our ability to effectively treat biofilm-related skin and soft-tissue infections caused by MRSA. Keywords: ethanolic plant extract, mecA expression, biofilm formation, skin infections Resistance of the bacteria to many marketed antibiotics has been rising dramatically due to antibiotic abuse in the communities and the hospitals. Thus, there is a continuous urge to find new treatment options for such infections. By looking back to traditional medicine, we found that herbs can also be used to treat some infections. This study focused on the use of a herbal extract named Ruta graveolens to test its activity on a highly antibiotic resistant bacteria named MRSA. This bacteria in known to cause various infections ranging from mild skin infections to life-threatening infections. The extract was found to have a potent killing effect on MRSA and also inhibit some major virulence factors that help the bacteria to establish the infection and become antibiotic resistant. Staphylococcus aureus ( S. aureus ) is a gram-positive commensal and opportunistic bacterium colonizing different body parts, such as the nostrils, axilla, and inguinal areas. It is the causative agent of many infections in hospitals and communities, ranging from skin and soft tissue infections to potentially life-threatening bloodstream infections. 1 Prevalence rates of MRSA among hospitalized patients in Egypt vary according to the geographical region, ranging from 24.4% 2 to 75%. 3 These prevalence rates are alarming, necessitating robust actions to combat this persistent health-care obstacle challenge. The virulence of S. aureus has risen with existence of Methicillin resistant S. aureus (MRSA) superbug. These strains carry the mecA gene that make them resistant to almost all beta-lactam antibiotics except -Abstract Truncated-
pharmacology & pharmacy,infectious diseases